Unredacted Mass. Lawsuit: Purdue Planned to Branch Out Into Addiction Treatment

Drug Industry Daily
A A
Newly unredacted portions of Massachusetts’ lawsuit against Purdue Pharma reveal details of the aggressive sales tactics the lawsuit claims the Oxycontin manufacturer used to increase sales of its opioid products.

To View This Article:

Login

Subscribe To Drug Industry Daily